August 15, 2012
Kaiser Permanente’s Archimedes IndiGO Helps Calculate Heart-Health Risk in HHS Sponsored Mobile App Challenge
Archimedes IndiGO, Kaiser Permanente’s unique decision support tool, was recently chosen as the risk assessment engine for the new $100,000 mobile app challenge sponsored by the Office of the National Coordinator. As part of the HHS Million Hearts Risk Check Challenge, the ONC is inviting developers to create a mobile app that helps consumers take a heart-health risk assessment, find places to get checked, and use the results to work with their doctor to develop a plan for improving their heart health.
Developed by Archimedes’ team members Don Morris, PhD, Josh Adler and David Eddy, MD, PhD, IndiGO is designed for use by patients, physicians, care managers and health coaches.
IndiGO quantifies the member’s risk of serious conditions, in this case heart health, and then prioritizes the actions the member can take to reduce his or her risk based on personal preferences. The result is a more informed and collaborative conversation between provider and member about care options, giving the member a sense of ownership in the decision-making process.
KAISER PERMANENTE MOBILE APPS
Jed Weissberg, MD, Kaiser Permanente senior vice president, Hospitals, Quality and Care Delivery (Dr. Weissberg also chairs the Archimedes board of directors) notes, “IndiGO is an important tool in helping to assess risk, but more importantly, can be leveraged to act as an invitation for conversation between provider and patient to help manage that risk. We want to aid in keeping the community at large heart-healthy, and IndiGO’s use in this ONC challenge helps to do just that.”
For more information on the challenge please go to: http://www.healthit.gov/buzz-blog/health-innovation/seeking-application-developers-million-hearts-risk-check-challenge/
Archimedes Inc. is a health care modeling organization. Its core technology — the Archimedes Model — is a clinically realistic, mathematical model of human physiology, diseases, interventions and health care systems. The model is continually validated by comparing the results of simulated trials to the results of real multi-national clinical trials and cohort studies.
Through innovations such as IndiGO and ARCHeS, Archimedes helps people understand the implications of their decisions and for the last 15 years has been relied upon to answer complex, real world questions for health plans, health systems, medical groups, pharmaceutical companies, researchers, and other organizations in the United States and Europe. Archimedes, is a subsidiary and innovation of Kaiser Permanente. For more information visit www.archimedesmodel.com.